Apellis Pharmaceuticals, Inc. (APLS)

20.90 -0.74 (-3.42%) USD  |  NASDAQ  |  Feb 27, 14:35
More

Apellis Pharmaceuticals Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Amneal Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade